One. Single. Dose.

Imagine a world where that’s all it takes to cure cancer.

Our breakthrough off-the-shelf technology can get us there.

TransJoin

TransSkip

OncoSkip

Our Mission

Our mission at Vironexis is to conduct preclinical development and early phase clinical trials of high, sustained and controllable protein therapeutics with a single shot.

Meet our team
what drives us

Creating a disease-free future

Combine gene therapy, virus therapy, and immunotherapy to create better, easier, and safer therapies for cancer and other diseases.

TransJoin
An off-the-shelf solution to achieve sustained expression of bispecific proteins, joining targeted cells together.
TransSkip
For applications requiring regulated gene therapy, turning transgene expression on or off when needed.
OncoSkip
A novel method for down regulating oncogene expression, drugging the previously undruggable. Combines with TransSkip to deliver a one-two punch to cancer.

Stay up to date and receive the latest news.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form